MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz: Recall - Particles Identified
May contain tiny plastic particles.
Italiano
May contain tiny plastic particles.
Questions Surrounding an Independent Third Party's Sterility Testing
Hospitals are unsafe places, but citizens perceive them as safe. Citizens, at least in Britain, are also unaware of the variations in performance among hospitals. I was at a meeting on quality in health care where the head of a patient organisation described his ideas of quality. He didn’t mention either safety or the quality of clinical care, two features that a senior doctor thought mattered most when talking about quality. Why, asked the senior doctor, didn’t he mention them?
Many adverse reactions have been discovered by spontaneous reporting, and this has led to important public health issues and drugs being removed from the market, in some cases issues are not so clear-cut as they may seem: in this respect the case of nimesulide hepatotoxicity is quite interesting.
About 1-5% of women develop hypertensive disorders in pregnancy and some of them are treated with antihypertensive drugs.1 Gestational hypertension increases the risk of preeclampsia1 and has been associated to negative outcomes in pregnancy, like spontaneous abortion, intrauterine growth restriction and premature delivery.2
Are these outcomes due to hypertension or drugs?
The first case-report in the National Pharmacovigilance Network
Spontaneous reporting data for Italy in 2012 will be shortly published by the AIFA1 portal. Numbers are once again surprising (Figure 1): more than 29,000 reports, with a 35% increase respect to 2011. The increase is higher for drugs (+41%) than for vaccines (+7%). The reporting rate (489 reports for one million inhabitants) has overcome countries with a strong tradition in Pharmacovigilance. For example, in the United Kingdom the yearly published data by MHRA show a quite stable reports-amount in the last 4 years, with a reporting rate of 409/million in 2012.2
L’Agenzia Europea dei Medicinali ha iniziato una rivalutazione di medicinali contenenti bromocriptina quando vengono assunti per via orale al fine di prevenire o sopprimere la lattazione in donne dopo il parto.
Il Pharmacovigilance Risk Assessment Committee (PRAC) dell’Agenzia Europea dei Medicinali ha raccomandato che le forme orali o suppositorie dei cosiddetti medicinali ‘beta-agonisti a breve durata d’azione’ non debbano più essere utilizzate per le indicazioni ostetriche (trattamento di donne incinte) quali il blocco del parto pretermine o delle contrazioni eccessive del parto.
80.211.154.110